Loading

logo

The Archives of Psychiatry

ISSN: 2995-8776

Research Article Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/Psychiatry.1.006

The Role of Patient-Reported Social Factors in Promoting Buprenorphine Consistency

Brenna Cook1, Michelle Eglovitch2, Dace Svikis2, Caitlin E Martin1,3,4,*
  • 1School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA
  • 2Department of Psychology, Virginia Commonwealth University, 23298, USA
  • 3Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA 23298, USA
  • 4Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA 23298, USA
+ Affiliations - Affiliations

Corresponding Author

Caitlin E Martin, Caitlin.martin@vcuhealth.org

Received Date: November 13, 2023

Accepted Date: December 27, 2023

Citation:

Cook B, Eglovitch M, Svikis D, Martin CE. The Role of Patient-Reported Social Factors in Promoting Buprenorphine Consistency. Arch Psychiatry. 2023;1(1):45-50.


Copyright: © 2023 Cook B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: While medications for opioid use disorder (MOUD) reduce overdose risk, inconsistent use can lead to substance use recurrence and compromise achieving optimal opioid use disorder (OUD) treatment outcomes. Research is limited on patient-reported perspectives on consistency of MOUD self-administration at home and its related social factors.

Objectives: The primary aim was to report on rates of patient-reported buprenorphine consistency among a sample receiving outpatient OUD treatment. The secondary aim was to explore differences in social determinants of health (SDOH) between patients reporting and not reporting lapses in buprenorphine dosing.

Methods: This is a secondary analysis from a cross-sectional survey and medical record abstraction study (N=96). The primary outcome was patient-reported buprenorphine consistency, as defined as no lapses in buprenorphine dosing in a preceding 28-day period. SDOH survey items were adapted from the Healthy People 2030 framework.

Results: Participants (n= 96) were three quarters female (74.0%); most identified as white (54.2%) or Black (38.9%). Most reported not missing any buprenorphine doses over the preceding 28-days (88.5%). Demographic and clinical variables were similar between buprenorphine consistency groups. Participants reporting no missed doses reported few negative social determinants of health (examples: 90% not needing help reading hospital materials and not being afraid that they would be hurt in their apartment building or house).

Discussion: These findings reinforce the known role of SDOH as strong predictors of treatment outcomes for chronic diseases (like substance use disorders), beyond contributions by demographic or clinical variables alone.

Conclusions: Future MOUD research should incorporate patient perspectives with the goal of informing patient-centered interventions. Scientific Significance: Promoting consistency in buprenorphine dosing using strategies grounded in patient experience could be an avenue to promote positive OUD treatment outcomes.

Keywords

Opioid use disorder, Buprenorphine, Substance use disorder, Medication for opioid use disorder, Social factors, Social determinates of Health, and Treatment

Recommended Articles

Primary Angiitis of the Central Nervous System (PACNS): A Commentary on a Proposed Screening Algorithm and an Update on Diagnosis and Treatment

Primary angiitis of the central nervous system (PACNS) is a rare disorder difficult to suspect in clinical practice due to its rarity, not specific/protean clinical presentation and imaging findings

The Role of Patient-Reported Social Factors in Promoting Buprenorphine Consistency

Background: While medications for opioid use disorder (MOUD) reduce overdose risk, inconsistent use can lead to substance use recurrence and compromise achieving optimal opioid use disorder (OUD) treatment outcomes. Research is limited on patient-reported perspectives on consistency of MOUD self-administration at home and its related social factors.

The Transformative Role of Artificial Intelligence in Psychiatry: Enhancing Diagnosis and Treatment

This article delves into the groundbreaking applications of artificial intelligence (AI) in psychiatry, revolutionizing the field and improving patient care. AI technologies have shown immense potential in augmenting diagnostic accuracy, predicting treatment outcomes, and facilitating personalized therapeutic interventions. This article reviews the latest advancements and discusses the ethical considerations associated with AI integration in psychiatric practice.

Bending the Curve Through Innovations to Overcome Persistent Obstacles in HIV Prevention and Treatment

Background: HIV/AIDS remains a major global public health challenge despite significant progress in treatment. New infections and HIV-related deaths persist, fueled by disparities in prevention and care access. Purpose: This review synthesizes recent advances across key domains - from vaccine development to novel treatments to omics approaches – that collectively hold promise for ending the HIV/AIDS pandemic.

Full Text
Cite
Download PDF
Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More